Over a period of more than two years, the man consumed between 8,000 and 12,000 international units (IU) of vitamin D daily
Tirzepatide has been licensed for the treatment of type 2 diabetes and given the metabolic issues and obesity that accompanies PCOS, it may be of value in its management for those PCOS patients who are obese with metabolic syndrome, although it may not benefit those who are of normal weight
Daily microdosing pushes it down to approximately 1.2, a 35% reduction
[DOI] [PMC free article] [PubMed] [Google Scholar] 114.Vijiaratnam N., Girges C., Auld G., Chau M., Maclagan K., King A., Skene S., Chowdhury K., Hibbert S., Morris H., et al
The only brand focused on optimizing both the circulatory and endocrine systems to support metabolism, inflammation response, and radiance from within